gms | German Medical Science

71. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
9. Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

21.06. - 24.06.2020

Growth progression in untreated glioblastoma

Tumorprogress bei unbehandelten Glioblastomen

Meeting Abstract

Suche in Medline nach

  • presenting/speaker Jessica Kren - Universitätsklinikum Schleswig-Holstein, Neurochirurgie, Lübeck, Deutschland
  • presenting/speaker Elisa Ducho - Universitätsklinikum Schleswig-Holstein, Neurochirurgie, Lübeck, Deutschland
  • Matteo Mario Bonsanto - Universitätsklinikum Schleswig-Holstein, Neurochirurgie, Lübeck, Deutschland

Deutsche Gesellschaft für Neurochirurgie. 71. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 9. Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie. sine loco [digital], 21.-24.06.2020. Düsseldorf: German Medical Science GMS Publishing House; 2020. DocP153

doi: 10.3205/20dgnc437, urn:nbn:de:0183-20dgnc4377

Veröffentlicht: 26. Juni 2020

© 2020 Kren et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Objective: Little is known about growth of glioblastoma. While meningiomas tend to grow proportionally slow, glioblastoma volume tends to explode in a short period of time. Since these tumours are highly aggressive, operative resection, if possible, should be planned shortly after diagnosis.

How long should a waiting period for glioblastoma resection be at most for optimal outcome?

Methods: In this retrospective, preliminary study the data of 102 patients were screened for diagnostic and pre-operative MRI-scans, which lay at least 7 days apart. Tumour volume was estimated in 27 cases. Diagnostic MRI-scans and pre-operative MRI-scans were compared. Volume was estimated using the BrainLab© cranial planning tool (Smart Brush). Waiting time and tumour growth were estimated, as were means and standard deviations (SD).

Results: In 27 cases, patients waited longer than 7 days for surgery, the least waiting time was 8 days, at most patients waited for 63 days. Mean and SD of waiting time between diagnostic MRI and pre-operative MRI were 21,33 ± 12,75 days. The mean age was 64 ± 12 years. Sizes of the tumours ranged from 0,18 to 55,9 cm3 with a mean of 21,48 ± 16,12 cm3 in diagnostic scans and from 0,8 to 56,1 cm3 with a mean of 25,99 ± 17,92 cm3 in pre-operative scans. 23 tumours grew significantly while 3 shrunk. Mean absolute growth was 4,5 ± 7,59 cm3 (from -16,6 cm3 to 25,9 cm3), while relative growth was 97,65 ± 222,94 % (from -54,6 to 1111,1 %). Correlation is moderately high with 0,57 between waiting time and tumour growth.

Conclusion: Not only time seems to determine tumour growth, but also factors, which are not visible in MRI scans. That is why an operative resection of possible glioblastoma should be planned as soon as possible to prevent exponential growth, which leads to greater neurological damage and could make resection quite more difficult. Further studies should focus on patient’s outcome.